Franco Valle

CIK 1699848 · Chief Financial Officer · last filed 2024-12-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.3K

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$1.65M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BMEA Chief Financial Officer 42,995 $1.17 $50.3K $173.4K 12 2024-12-02
Eidos Therapeutics, Inc. (EIDX) Delisted Senior Vice President, Finance 0 -$1.82M 7 2021-01-13

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-12-07 BMEA Grant (A) $0 EDGAR
2021-08-05 BMEA Grant (A) $0 EDGAR
2021-01-28 Disp (D) $0
2021-01-13 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed -$384.1K EDGAR
2020-11-10 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed -$109.9K EDGAR
2020-10-09 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed −444 -$724.1K EDGAR
2020-06-05 Eidos Therapeutics, Inc. (EIDX) Delisted Grant (A) +444 $18.5K EDGAR
2020-04-22 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed -$85.1K EDGAR
2020-03-30 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed -$205.1K EDGAR
2020-03-04 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed -$135.3K EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.